Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02472977
Title Safety and Efficacy Study of Ulocuplumab and Nivolumab in Subjects With Solid Tumors
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

lung small cell carcinoma

pancreatic adenocarcinoma

Therapies

Nivolumab

Ulocuplumab

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University Of Colorado Hosp Aurora Colorado 80045 United States Details
Indiana University Health Indianapolis Indiana 46202 United States Details
Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins Baltimore Maryland 21287 United States Details
Columbia University Medical Center (Cumc) New York New York 10032 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
Local Institution Helsinki 00029 Finland Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field